Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Could Eli Lilly Successfully Treat Heart Failure With Its Diabetes Drug?


Eli Lilly (NYSE: LLY) made more than $1.1 billion last year from Jardiance in treating type 2 diabetes. The company could be on its way to making even more money with the drug after reporting successful results from a late-stage study for heart failure. In this Motley Fool Live video recorded on July 7, Motley Fool contributors Keith Speights and Brian Orelli discuss Lilly's latest results.

Continue reading


Source Fool.com

Like: 0
LLY
Share

Comments